Admission and fasting plasma glucose for estimating risk of death of diabetic and nondiabetic patients with acute coronary syndrome: nonlinearity of hazard ratios and time-dependent comparison

American Heart Journal

Volumn 158, Issue 6, 2009, Pages 989-997

  Cid Alvarez, Belen ^a   Gude, Francisco ^a   Cadarso Suarez, Carmen ^b   Gonzalez Babarro, Eva ^a   Rodriguez Alvarez, Maria Xose ^b   Garcia Acuna, Jose Maria ^a   Gonzalez Juanatey, Jose Ramon ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SURVIVOR;

ACUTE CORONARY SYNDROME; AGED; BLOOD GLUCOSE; DIABETIC ANGIOPATHIES; FASTING; FEMALE; HUMANS; MALE; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; TIME FACTORS;

EID: 70549111163     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.10.004     Document Type: Article

References (34)

1. Kosuge M., Kimura K., Kojima S., et al. Japanese Acute Coronary Syndrome Study (JACSS) Investigators. Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. Circ J 69 (2005) 375-379
2. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
3. Timmer J.R., Van der Horst I.C., Ottervanger J.P., et al. Myocardial Infarction Study Group. Prognostic value of admission glucose in nondiabetic patients with myocardial infarction. Am Heart J 148 (2004) 399-404
4. Wahab N.N., Cowden E.A., Pearce N.J., et al., on behalf of the ICONS investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol 40 (2002) 1748-1754
5. Zeller M., Cottin Y., Brindisi M.C., et al. The RICO survey working group. Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction. Eur Heart J 25 (2004) 308-312
6. Vis M.M., Sjauw K.D., Van der Schaaf R.J., et al. In patients with ST-elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes. Am Heart J 154 (2007) 1184-1190
7. Suleiman M., Hammerman H., Boulos M., et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 111 (2005) 754-760
8. Straumann E., Kurz D.J., Muntwyler J., et al. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention. Am Heart J 150 (2005) 1000-1006
9. Kosiborod M., Rathore S.S., Inzucchi S.E., et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction. Implications for patients with and without recognized diabetes. Circulation 111 (2005) 3078-3086
10. Kosiborod M., Inzucchi S.E., Krumholz H.M., et al. Glucometrics in patients hospitalized with acute myocardial infarction. Defining the optimal outcomes-based measure of risk. Circulation 117 (2008) 1018-1027
11. Svensson A.M., McGuire D.K., Abrahamsson P., et al. Association between hyper- and hypoglycaemia and 2 year all-cause risk in diabetic patients with acute coronary syndrome. Eur Heart J 26 (2005) 1255-1261
12. Ainla T., Baburin A., Teesalu R., et al. The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med 22 (2005) 1321-1325
13. 1c in acute myocardial infarction. Diabet Med 21 (2004) 305-310
14. Ray K.K., Cannon C.P., Morrow D.A., et al. Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. Eur Heart J 28 (2007) 806-813
15. Aronson D., Hammerman H., Kapeliovich M.R., et al. Fasting glucose in acute myocardial infarction. Diabetes Care 30 (2007) 960-966
16. Cadarso-Suárez C., Meira-Machado L., Kneib T., et al. Flexible hazard ratio curves for continuous predictors in multi-state models: an application to breast cancer data. Statistical Modelling (2009) [in press]
17. De Boor C.A. A practical guide to splines. Revised Edition (2001), Springer-Verlag, New-York
18. Therneau T.M., and Grambsch P.M. Modelling survival data: extending the Cox model (2000), Springer, Berlin
19. Heagerty P.J., and Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics 61 (2005) 92-105
20. Pinto D.S., Skolnick A.H., Kirtane A.J., et al., TIMI Study Group. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 45 (2005) 178-183
21. Vivas D., García-Rubira J.C., González-Ferrer J.J., et al. Prognostic value of first fasting glucose measurement compared with admission glucose level in patients with acute coronary syndrome. Rev Esp Cardiol 61 (2008) 458-464
22. Spyer G., Hattersley A.T., McDonald I.A., et al. Hypoglycaemic counter-regulation at normal blood glucose concentrations in patients with well controlled type-2 diabetes. Lancet 356 (2000) 1970-1974
23. Fisman E.Z., Motro M., Tenenbaum A., et al. Is hypoglycaemia a marker for increasing long-term mortality risk in patients with coronary artery disease? An 8-year follow-up. Eur J Cardiovasc Prev Rehabil 11 (2004) 135-143
24. Lindstrom T., Jorfeldt L., Tegler L., et al. Hypoglycaemia and cardiac arrhythmias in patients with type 2 diabetes mellitus. Diabet Med 9 (1992) 536-541
25. Service F.J. Hypoglycemic disorders. N Engl J Med 332 (1995) 1144-1152
26. Oswald G.A., Smith C.C.T., Betteridge D.J., et al. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. BMJ 293 (1986) 917-922
27. Oswald G.A., Smith C.C., Delamothe A.P., et al. Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction. Br Heart J 59 (1988) 663-671
28. Liu Q., Docherty J.C., Rendell J.C.T., et al. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation. J Am Coll Cardiol 39 (2002) 718-725
29. Oliver M.F., and Opie L.H. Effects of glucose and fatty acids on myocardial ischaemia and arrythmias. Lancet 343 (1994) 155-158
30. Takahashi T., Hiasa Y., Ohara Y., et al. Acute hyperglycaemia prevents the protective effect of pre-infarction angina on microvascular function after primary angioplasty for acute myocardial infarction. Heart 94 (2008) 1402-1406
31. Kersten J.R., Toller W.G., Tessmer J.P., et al. Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism. Am J Physiol Heart Circ Physiol 281 (2001) H2097-H2104
32. Tenerz A., Norhammar A., Silveira A., et al. Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 26 (2003) 2770-2776
33. Goldberg R.J., Kramer D.G., Lessard D., et al. Serum glucose levels and hospital outcomes in patients with acute myocardial infarction without prior diabetes: a community-wide perspective. Coron Artery Dis 18 (2007) 125-131
34. Bartnik M., Rydén L., Ferrari R., et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: The Euro Heart Survey on diabetes and the heart. Eur Heart J 25 (2004) 1880-1890